Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Gross Margin (2020 - 2025)

Celularity (CELU) has disclosed Gross Margin for 6 consecutive years, with 79.68% as the latest value for Q4 2025.

  • For Q4 2025, Gross Margin rose 88762.0% year-over-year to 79.68%; the TTM value through Dec 2025 reached 24.39%, down 3485.0%, while the annual FY2025 figure was 24.39%, 4796.0% down from the prior year.
  • Gross Margin hit 79.68% in Q4 2025 for Celularity, down from 26.12% in the prior quarter.
  • Across five years, Gross Margin topped out at 92.94% in Q3 2021 and bottomed at 967.3% in Q4 2024.
  • Average Gross Margin over 5 years is 2.7%, with a median of 57.18% recorded in 2022.
  • Year-over-year, Gross Margin plummeted -98796bps in 2024 and then surged 88762bps in 2025.
  • Celularity's Gross Margin stood at 42.79% in 2021, then tumbled by -103bps to 1.26% in 2022, then soared by 1741bps to 20.67% in 2023, then plummeted by -4781bps to 967.3% in 2024, then soared by 92bps to 79.68% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 79.68%, 26.12%, and 8.61% for Q4 2025, Q3 2025, and Q2 2025 respectively.